Treatment of massive cecal bleeding in a 28-Year-old patient with homozygous factor V deficiency with activated factor VII.

Factor V deficiency is usually accompanied with recurrent epistaxis, menorrhagia and haemorrhages after trauma. So far, gastrointestinal bleeding has not been reported. We describe here the first case of severe cecal bleeding in a 28-year-old woman with homozygous factor V deficiency. As a reasonable alternative to large amounts of fresh frozen plasma, we indicated recombinant activated factor VII (rFVIIa), as supra-physiological concentrations directly activate factor X and prothrombin on the surface of activated platelets. With this regimen, the bleeding immediately stopped and the patient was discharged three days later. Rotation thromboelastometry studies showed a marked improvement in clot generation after rFVIIa infusion. We conclude that massive cecal mucosal bleeding is a possible manifestation of homozygous factor V deficiency and rFVIIa could be a successful therapy.
AuthorsS Petros, J Fischer, J Mössner, I Schiefke, N Teich
JournalZeitschrift für Gastroenterologie (Z Gastroenterol) Vol. 46 Issue 3 Pg. 271-3 (Mar 2008) ISSN: 0044-2771 [Print] Germany
PMID18322882 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Coagulants
  • Factor VIIa
  • Adult
  • Cecal Diseases (drug therapy, etiology)
  • Coagulants (administration & dosage)
  • Factor VII Deficiency (complications, drug therapy)
  • Factor VIIa (administration & dosage)
  • Female
  • Gastrointestinal Hemorrhage (drug therapy, etiology)
  • Humans
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password:
Type Validation Code Shown: